Methylphenidate (Ritalin)
Methylphenidate, commonly known by the brand name Ritalin, is a prescription medication used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy. Studies have found that methylphenidate can effectively improve focus and reduce impulsive behaviors in individuals with ADHD. Extended-release formulations of methylphenidate, such as Ritalin LA, provide sustained symptom control throughout the day. Behavioral studies in rats also indicate that methylphenidate can enhance cognitive function and reduce hyperactivity.
Methylphenidate has been associated with renal impairment, particularly in patients with pre-existing kidney conditions. The risk is higher with prolonged use or cumulative exposure. Additionally, there have been reports of misuse and abuse of methylphenidate, especially among adolescents and young adults seeking performance enhancement.
The evidence for some of these findings is based on cohort studies with moderate strength, indicating that while the associations are noteworthy, further research may be needed to fully understand the long-term effects and risks.
Sources
- Extended-release methylphenidate (Ritalin LA). (PMID:12381228)
- Methylphenidate (ritalin). (PMID:567847)
- Methylphenidate (Ritalin): behavioral studies in the rat. (PMID:17454243)
- Methylphenidate (Ritalin). (PMID:5787081)
- Methylphenidate (Ritalin) abuse. (PMID:271231)
- Age-dependent effects of cumulative methylphenidate exposure on brain structure and symptom amelioration in youth with ADHD: A longitudinal MRI study. (PMID:40527386)
_Worker-drafted node, Hermes writer enrichment, pending editorial review._
Connections
Methylphenidate (Ritalin) is a side effect of
Sources
- Extended-release methylphenidate (Ritalin LA). (2002) pubmed
- Methylphenidate (ritalin). (1978) pubmed
- Methylphenidate (Ritalin): behavioral studies in the rat. (2007) pubmed
- Methylphenidate (Ritalin). (1969) pubmed
- Methylphenidate (Ritalin) abuse. (1977) pubmed
- Age-dependent effects of cumulative methylphenidate exposure on brain structure and symptom amelioration in youth with ADHD: A longitudinal MRI study. (2025) pubmed
- Serotonin-dopamine interactions in psychostimulant-induced gene regulation: SSRI antidepressants potentiate gene regulation by methylphenidate (Ritalin) in the striatum and enhance behavioral profile indicative of addiction liability in rodents. (2025) pubmed
- Ritalin (methylphenidate): clinical experiences. (1959) pubmed
- Methylphenidate (ritalin). (1979) pubmed
- Psychophysiological effects of methylphenidate (Ritalin). (1987) pubmed